NCT00002169已完成2 期
A Phase II, Randomized, Placebo-Controlled Study to Determine the Effects of Viracept on the Clinical Outcome of Cytomegalovirus (CMV) Retinitis in AIDS Patients Who Are Receiving Standard Induction and Maintenance Therapy for This Infection
Agouron Pharmaceuticals16 个研究点 分布在 1 个国家开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 试验地点
- 16
研究概览
简要总结
The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are already being treated for cytomegalovirus (CMV) retinitis.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 13 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must have:
- •HIV infection.
- •Newly diagnosed or first progression of CMV retinitis.
排除标准
- •Prior Medication:
- •Prior therapy (or less than 2 weeks) with protease inhibitor other than saquinavir.
研究者
研究点 (16)
Loading locations...
相似试验
已完成
2 期
A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)Mycobacterium Avium-Intracellulare InfectionHIV InfectionsNCT00002170Agouron Pharmaceuticals
已完成
不适用
A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive PatientsHIV InfectionsNCT00002426Gilead Sciences390
已完成
1 期
Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive SubjectsAsymptomatic HIV InfectionNCT02456558ApoPharma30
暂停
2 期
Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected PatientsHIV InfectionsNCT00004999Agouron Pharmaceuticals350
终止
2 期
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsHIV InfectionsNCT00002418Bristol-Myers Squibb25